Your browser doesn't support javascript.
loading
The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma.
Alban, Tyler J; Grabowski, Matthew M; Otvos, Balint; Bayik, Defne; Wang, Wesley; Zalavadia, Ajay; Makarov, Vlad; Troike, Katie; McGraw, Mary; Rabljenovic, Anja; Lauko, Adam; Neumann, Chase; Roversi, Gustavo; Waite, Kristin A; Cioffi, Gino; Patil, Nirav; Tran, Thuy T; McCortney, Kathleen; Steffens, Alicia; Diaz, C Marcela; Brown, J Mark; Egan, Kathleen M; Horbinski, Craig M; Barnholtz-Sloan, Jill S; Rajappa, Prajwal; Vogelbaum, Michael A; Bucala, Richard; Chan, Timothy A; Ahluwalia, Manmeet S; Lathia, Justin D.
Afiliação
  • Alban TJ; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute.
  • Grabowski MM; Center for Immunotherapy and Precision Oncology, and.
  • Otvos B; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, USA.
  • Bayik D; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, USA.
  • Wang W; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute.
  • Zalavadia A; Nationwide Children's Hospital, Institute for Genomic Medicine, Departments of Pediatrics and Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Makarov V; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute.
  • Troike K; Center for Immunotherapy and Precision Oncology, and.
  • McGraw M; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute.
  • Rabljenovic A; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, USA.
  • Lauko A; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute.
  • Neumann C; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute.
  • Roversi G; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute.
  • Waite KA; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute.
  • Cioffi G; Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program, Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland, USA.
  • Patil N; Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program, Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland, USA.
  • Tran TT; University Hospitals Research and Education Institute, Cleveland, Ohio, USA.
  • McCortney K; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.
  • Steffens A; Departments of Pathology and Neurosurgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
  • Diaz CM; Departments of Pathology and Neurosurgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
  • Brown JM; Center for Immunotherapy and Precision Oncology, and.
  • Egan KM; Department of Cardiovascular & Metabolic Sciences and Imaging Core, Lerner Research Institute.
  • Horbinski CM; Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio, USA.
  • Barnholtz-Sloan JS; Case Comprehensive Cancer Center, Cleveland, Ohio, USA.
  • Rajappa P; Departments of Pathology and Neurosurgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
  • Vogelbaum MA; Departments of Pathology and Neurosurgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
  • Bucala R; Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program, Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland, USA.
  • Chan TA; Nationwide Children's Hospital, Institute for Genomic Medicine, Departments of Pediatrics and Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Ahluwalia MS; Departments of Cancer Epidemiology and Neuro-Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.
  • Lathia JD; Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.
JCI Insight ; 8(13)2023 07 10.
Article em En | MEDLINE | ID: mdl-37252795
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fatores Inibidores da Migração de Macrófagos / Glioblastoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: JCI Insight Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fatores Inibidores da Migração de Macrófagos / Glioblastoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: JCI Insight Ano de publicação: 2023 Tipo de documento: Article